Member Info for B2HS2L

Once non-NCYT share holders cotton-on to the wonders of SNP-sig, and how far into the future diagnostic systems like it will be necessary, the current short-termism will evaporate, and will be noticeable by the increase in p/e.
Can't predict a time scale for this, but I'm convinced it will be well worth waiting for.
Let's see how sales go with LFT's soon.
Steady as she goes.

Saintsmith - for your info:

https://www.lse.co.uk/rns/NCYT/completion-of-novaprep174-business-sale-rxqni7r68dtcdl9.html

Yes.

One of the guests is Paul Eros - Chief Business Officer at Novacyt Group.
I doubt he will be giving away any state secrets, but lets hope he can provide context and depth to the discussion.

I asked my father what his computer password was.
He said:
MickeyMinnieGoofyDonaldPlutoHueyLewyDewyDublin

Intrigued I said "what kinda password is that"?

His response was "Well I had to have 8 characters and a capital."

+++
Done deal..

Then surely they are all late to the party don't you think?
This dispute has served GM well in this respect.
There are French and British Govnt polcy disincentives to negotiate as well.

correction - number one customer

Dartron, -
The DHSC dispute IMO is stopping those with a mind to make an offer for NCYT at the moment.
As GM wants THE OPPORTUNITY to build a mid-cap company, there is nothing better than a dispute with the number one company to stop bids arriving. All the time GM is not dealing with bids he is growing the business, and mid-cap status is near at hand. GM won't finish with DHSC until he has to, - but that still might be soon.

I'm thinking that something material to the share price is being transacted on Monday, that can also be reported on Tuesday, is the reason that the 2020 Full year results have been moved forward.

There is a lot to be achieved by the end of June 2021,.
1 Acquisition in H1,
2 new products expected to be launched soon.
The delayed finances to be dealt with first, then the delivery of much that is overdue, none of it bad IMO.

Why do you guys doubt that 300 instruments were not delivered after 29.09.2020?

"This first phase of the contract will involve the immediate deployment of 300 PCR instruments..."

Shaun -
How many positive cases yesterday, over 9k
Therefore perhaps over 9K SNPsig tests per day?
In order to find the variants, SNPsig or a test like it must be used on the positive sample.
Most positive samples we are lead to believe will be the India variant.
Not sure there are many manufacturers that have yet developed an 'India' variant test other than Novacyt.
That is our Unique offering, - speed of development and speed to market.

Whan I was searching, the term " VoC Framework" only seemed to be in use in the 17.05.2021 Novacyt RNS.

Wilson, in a previous post you floated the idea that the other 3 'entities' are "Surely they are therefore not public companies".
I think you may be right about this.

I have looked hard for the other 3 companies and nothing comes up.
Wilson has also looked and drawn a blank.

Shaun, - at present I think 'genotype assay testing' is another way of saying 'Genomic Surveillance'. - but I could be wrong.

Just googled 'genotype assay testing' and this came up - :
23.03.2021 - https://www.nationalhealthexecutive.com/articles/genotype-assay-testing-technology-variants-concern

The text used in this link are similar / the same as the link in my last post, so can't see yet why my above assumption is wrong.

16.06.2021 - Guidance - NHS Test and Trace: how we test your samples

https://www.gov.uk/government/publications/nhs-test-and-trace-how-we-test-your-samples/nhs-test-and-trace-how-we-test-your-samples

Future of testing emphasised within "The importance of the national laboratory network".

Also
"A new very high throughput laboratory in Royal Leamington Spa will also begin processing tests soon."

Also
"Automation and technology
As well as building a vast new laboratory network, NHS Test and Trace has invested in new innovative testing technology which means we can operate faster and with increased capacity and develop a flexible pandemic response infrastructure that can respond to surges in demand.

This includes the LGC Biosearch Technologies’ EndPoint PCR (EPCR) testing system for COVID, which has ultra-high capacity and can process up to 150,000 tests each day on a single instrument with a lower cost per test than current RT qPCR. We intend to use this technology in our two largest labs; Royal Leamington Spa and Milton Keynes.

In addition, new technology to rapidly detect COVID mutations indicating whether positive test samples contain known variants is being rolled out by the government in NHS Test and Trace laboratories.

The technology – known as ‘genotype assay testing’ – is set to halve the time it currently takes to identify if a positive COVID-19 sample contains a mutation indicative of a known variant of concern, and will be used in addition to standard testing for COVID-19 to identify cases quickly.

Genotype assays complement existing surveillance work that uses genomic sequencing to look for variants in COVID-positive samples. Genomic sequencing surveillance will continue to detect new variants and mutations. Where new variants or mutations are identified, the technology can be adapted to test for them as well, meaning the technology can be easily deployed to track the variants of most concern."

+++
Probably posted before:

Research and analysis - Evaluation of endpoint PCR (EPCR) as a central laboratory based diagnostic test technology for SARS-CoV-2
Published 28 January 2021

https://www.gov.uk/government/publications/evaluation-of-endpoint-pcr-epcr-as-a-diagnostic-test-technology-for-sars-cov-2/evaluation-of-endpoint-pcr-epcr-as-a-central-laboratory-based-diagnostic-test-technology-for-sars-cov-2

7. Conclusions - Most important

+++

Suspect larger Lighthouse labs will be using the UltraDX SARS-CoV-2 N1/N2/RP assay (LGC, Biosearch Technologies), and are not using Covid-HT direct.

These links encompassing UK govnt policy towards Takeover of businesses active in fight against Covid -19,
MAY cause a predator to think twice about a bid.

https://www.gov.uk/government/publications/enterprise-act-2002-guidance-on-changes-to-the-turnover-and-share-of-supply-tests-for-mergers-orders-2020

https://www.gov.uk/government/news/new-protections-for-uk-businesses-key-to-national-security-and-fight-against-coronavirus

How do you petition Parliament?
Create or sign a petition that asks for a change to the law or to government policy.
After 10,000 signatures, petitions get a response from the government.
After 100,000 signatures, petitions are considered for debate in Parliament.

Petition Parliament and the government - GOV.UK
https://www.gov.uk/petition-government

Looking for evidence airlines are restarting routes.
It's possible it's in this lot, but saving this for an insomnia attack:

https://www.routesonline.com/news/tagged/8549/covid-19/